Atropine sulfate blocks the muscarinic receptors in the salivary glands and leads to reduced saliva production. There are no published studies about its use in children with cerebral palsy. Objective ...
Aquestive Therapeutics Inc. made misleading statements about the progress of its FDA application for a new sublingual drug for anaphylaxis, an investor alleges in a suit filed Thursday. Aquestive and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results